News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Elizabeth Preston, STAT | 07.07.2016
When physicist Alex Zhavoronkov looked in the mirror one day and saw alarming swelling around his eyes, he guessed it...
By Clare Wilson, New Scientist | 07.07.2016

Can light restore hearing in deaf people? Researchers hope that through optogenetics, they can use micro-LED lights to make...

By Alice Bell, The Guardian | 07.06.2016

Brexit has thrown British science into a mess. During this period of political upheaval, it might be tempting to...

a mouse
By The Irish Examiner, The Irish Examiner | 07.06.2016

Hidden effects on metabolism and ageing may make it harder to rid future generations of devastating inherited diseases using a...

By Tom Mendelsohn, ARS Technica | 07.06.2016

In 1975, the Swedish government decided it could help medical research by collecting a blood sample from every child born...

By Will Jackson & Vandy Muong, The Phnom Penh Post | 07.06.2016

A US-based commercial surrogacy agency, Surrogacy Cambodia, has begun marketing to US citizens “personalised services” – including surrogacy and gender...

By A. Gordon Smith, Harvard Business Review | 07.06.2016

I met Tony in 2001 when he was sent to me with severe muscle weakness. Confined to a wheelchair and unable to...

By Sheila Kaplan, STAT | 07.06.2016

For years, ethicist Arthur Caplan warned medical researchers that paying businesses to evaluate their clinical trials was a bad idea...